Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Iot symbols : Pmcb save search
PharmaCyte Biotech Reports Third Quarter Financial Results and Operational Highlights
Published: 2022-03-16 (Crawled : 13:30) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: 2.4%
H: 1.88%
C: -2.82%
financial results report results biotech iot tiona
PharmaCyte Biotech Announces Genetic Stability of Cytochrome P450 Gene and Site of Integration
Published: 2022-02-22 (Crawled : 18:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: -1.99%
H: 3.05%
C: -0.51%
genetic ces integration biotech iot
PharmaCyte Biotech Updates Status of Investigational New Drug Application to FDA
Published: 2022-02-14 (Crawled : 15:30) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: -2.31%
H: 1.9%
C: -3.79%
new drug fda application drug biotech iot
PharmaCyte Biotech Study Proves Capsule Material Is Not Toxic For Encapsulated Cells
Published: 2022-01-04 (Crawled : 16:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: -0.36%
H: 0.72%
C: -2.17%
cel biotech iot
PharmaCyte Biotech Successfully Completes 36 Month Master Cell Bank Stability Study
Published: 2021-12-28 (Crawled : 15:30) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: 1.93%
H: 0.0%
C: -4.17%
cel biotech iot
PharmaCyte Biotech Reports Second Quarter 2021 Financial Results and Operational Highlights
Published: 2021-12-15 (Crawled : 15:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: 0.0%
H: 7.5%
C: 6.67%
financial results results biotech iot
PharmaCyte Biotech Successfully Completes Cytochrome P450 Site of Integration DNA Sequencing Assay
Published: 2021-12-08 (Crawled : 16:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: -1.56%
H: 5.56%
C: 3.17%
integration biotech iot
PharmaCyte Biotech Launches Malignant Ascites Program with Commencement of Pivotal Preclinical Study
Published: 2021-11-30 (Crawled : 09:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: 2.31%
H: 0.0%
C: 0.0%
preclinical biotech iot pre-clinical
PharmaCyte Biotech Announces Cell Encapsulation Technology Material Does Not Cause Skin Irritation
Published: 2021-11-12 (Crawled : 18:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: 0.36%
H: 0.0%
C: 0.0%
biotech technology iot skin
PharmaCyte Biotech Announces Encapsulation Material Does Not Alter Cellular DNA
Published: 2021-09-27 (Crawled : 14:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: 0.0%
H: 3.03%
C: 0.0%
biotech iot
PharmaCyte Biotech Releases More Positive Results From FDA-Required Biocompatibility Tests
Published: 2021-09-21 (Crawled : 14:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: 5.84%
H: 1.97%
C: -0.05%
fda positive results test positive results biotech iot
PharmaCyte Biotech Announces Positive Results of Biocompatibility Study for FDA
Published: 2021-09-16 (Crawled : 14:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: 14.37%
H: 2.88%
C: -8.38%
fda positive results positive results biotech iot
PharmaCyte Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
Published: 2021-09-08 (Crawled : 14:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: -0.62%
H: 7.14%
C: 6.21%
biotech iot conference
PharmaCyte Biotech Establishes 18-Month Shelf Life for Clinical Trial Product in Ongoing Stability Study
Published: 2021-08-31 (Crawled : 14:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: 2.12%
H: 2.08%
C: 0.0%
ongoing biotech iot trial
PharmaCyte Biotech Expands Product Pipeline to Include Diabetes and Malignant Ascites Following $90-Million Capital Raise
Published: 2021-08-25 (Crawled : 14:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: 3.93%
H: 1.62%
C: -4.86%
diabetes biotech iot
PharmaCyte Biotech Announces Closing of $70 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Published: 2021-08-23 (Crawled : 00:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: 5.17%
H: 3.55%
C: 0.0%
offering biotech iot
PharmaCyte Biotech Announces $70 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Published: 2021-08-19 (Crawled : 12:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: -57.88%
H: 3.12%
C: -16.55%
offering biotech iot nasdaq
PharmaCyte Biotech Releases Statement on Nasdaq Uplisting and Current Business Focus
Published: 2021-08-16 (Crawled : 19:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: -8.15%
H: 13.53%
C: -1.45%
biotech iot nasdaq
PharmaCyte Biotech Announces Closing of $15-Million Public Offering
Published: 2021-08-12 (Crawled : 21:00) - biospace.com/
PMCB | $2.2 3.29% 1.4% 12K
|
Manufacturing
|
| O: 1.05%
H: 2.08%
C: -21.11%
offering biotech iot publication
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.